Evidence map›Paper›PMID 35902827›Full record

SynthesisBMC infectious diseases2022

Evidence underscoring immunological and clinical pathological changes associated with Sarcoptes scabiei infection: synthesis and meta-analysis.

Christina Næsborg-Nielsen, Vicky Wilkinson, Natalia Mejia-Pacheco, Scott Carver

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Making the most of mortalities: Novel host-parasite records in a sandy inland mouse (International journal for parasitology. Parasites and wildlife · 2025
    Article
  5. Pharmacokinetics and safety of topical fluralaner in koalasInternational journal for parasitology. Parasites and wildlife · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Artificial Infestation ofInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Diseases of Iberian ibex (European journal of wildlife research · 2023
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christina Næsborg-NielsenDepartment of Biological Sciences, University of Tasmania, Private Bag 55, Hobart, TAS, Australia. christina.naesborgnielsen@utas.edu.au.
Vicky WilkinsonDepartment of Biological Sciences, University of Tasmania, Private Bag 55, Hobart, TAS, Australia.
Natalia Mejia-PachecoDepartment of Biological Sciences, University of Tasmania, Private Bag 55, Hobart, TAS, Australia.
Scott CarverDepartment of Biological Sciences, University of Tasmania, Private Bag 55, Hobart, TAS, Australia.
University of Tasmania · AU

Funding

Australian Research Councel Linkage Programme LP180101251
6 · The paper itself

Abstract

backgroundSarcoptes scabiei is one of the most impactful mammalian parasites. There has been much research on immunological and clinical pathological changes associated with S. scabiei parasitism across a range of host species. This rich body of literature is complex, and we seek to bring that complexity together in this study. We first (1) synthesise narrative reviews of immunopathological relationships to S. scabiei infection to construct overarching hypotheses; then (2) undertake a systematic meta-analysis of primary literature on immunological and clinical pathological changes; and lastly (3) contrast our findings from the meta-analysis to our synthesis from narrative reviews.

methodsWe synthesised 55 narrative reviews into two overarching hypotheses representing type I and type IV immune responses to S. scabiei infection. We then systematically extracted all literature reporting immunological variables, acute phase proteins, oxidant/antioxidant status, and erythrocytic, hepatological and nephrological changes, calculating 565 effect sizes between controls and sarcoptic mange affected groupings, refining (simplifying) hypotheses from narrative reviews.

resultsImmunological and clinical pathological parameters were most often studied in dogs (n = 12) and humans (n = 14). Combining immunological and clinical pathological information across mammalian species (n = 19) helped yield general insights into observed disease responses. This is evidenced by interspecific consensus in 27 immunological and clinical pathology variables (6/26 type I hypersensitivity, 3/20 type IV hypersensitivity, 6/10 oxidant/antioxidant status, 3/6 acute phase protein, 4/7 erythrocytic, and 5/10 hepatological/nephrological).

conclusionsElevated IgE, eosinophils and mast cells in type I hypersensitivity response corresponded to what was described in narrative reviews. Results from type IV hypersensitivity response suggested typical antibody response, however cell-mediated response was less evident. Some consensus of acute phase protein response and shifted oxidant/antioxidant balance and slight evidence of anemia. We highlight the need for mange/scabies studies to more routinely compare immunological and clinical pathological changes against controls, and include collection of a more standardised suite of variables among studies.

Indexed as

Hypersensitivity, DelayedHypersensitivity, ImmediatePathology, ClinicalScabiesAcute-Phase ProteinsAnimalsAntioxidantsDogsHumansMammalsOxidantsSarcoptes scabieiAcute-Phase ProteinsAntioxidantsOxidantsImmunologyMeta-analysisPathologySarcoptes scabieiSarcoptic mangeScabies

Identifiers

PMID35902827
PMCPMC9335973
OpenAlexW4288435829

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.